Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS)

Kim, Tae Nyun; Park, Man Sik; Lim, Kyung Taek; Yang, Sae Jeong; Yoo, Hye Jin; Kang, Hyun Joo; Song, Wook; Seo, Ji A; Kim, Sin Gon; Kim, Nan Hee; Baik, Sei Hyun; Choi, Dong Seop; Choi, Kyung Mook

doi:10.1016/j.diabres.2011.06.013

Cited by 133 publications

(123 citation statements)

References 33 publications

Supporting

Mentioning

111

Contrasting

Unclassified

Order By: Relevance

“…Abdominal fat and CI, despite not having cutoff points to identify individuals with greater propensity to CVD, are considered by several studies as factors directly related to cardiovascular risk, as they are indicative of central obesity (Costa, Soares, Lemos, Maranhao, & Azevedo, 2010;Kim et al, 2011;Pitanga & Lessa, 2005) and DXA can be an interesting method for estimating body fat, including visceral fat (Kaul et al, 2012;Toombs, Ducher, Shepherd, & De Souza, 2012). However, this study observed a trend of sarcopenia only as a risk factor for body fat.…”

Section: Discussioncontrasting

confidence: 49%

“…More recent studies (Kim et al, 2011;Lim et al, 2010) consider sarcopenic obesity as the combination of factors adopted for predicting obesity and sarcopenia, with prevalence of 5.7% in women aged ≥ 65 years. The present study showed prevalence of 24.2% of women classified as obese-sarcopenic, with the same obesity and sarcopenia criteria shown in Table 5.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Sarcopenia and cardiovascular risk in physically active adult and elderly women

Castro

Lima

Cerqueira³

et al. 2014

Motriz: rev. educ. fis.

View full text Add to dashboard Cite

Abstract-The purpose of this study was to assess the prevalence of sarcopenia and its association with risk factors for cardiovascular diseases (CVD) in non-sedentary women. Study participants were 124 women (control group (CG) n = 33; 24.5 ± 2.9 years and study group (SG) n = 91; 61.9 ± 8.7 years). Anthropometric measurements, blood parameters, body composition (DXA), anthropometric indices and questionnaire answers were analyzed. Sarcopenia was considered as a standard deviation below mean values for young people, corresponding to 7.3 kg/m² and classifying 34.1% of SG as sarcopenic. Prevalence of risk for CVD considered low, moderate and high was 21%, 60% and 19%, respectively. Logistic regression showed no relationship between sarcopenia and risk factors for CVD, except for body mass index as a protection factor. There was a tendency for sarcopenia to assume associations as risk factor for variables smoking, triglycerides, obesity, abdominal fat, and Framingham Risk Score and as a protection factor for variable physical activity level. Keywords: sarcopenia, cardiovascular risk factors, womenResumo-"Sarcopenia e risco cardiovascular em mulheres adultas e idosas fisicamente ativas." Objetivou-se verificar a prevalência de sarcopenia e sua associação com fatores de risco para doenças cardiovasculares (DCV) em mulheres fisicamente ativas. Participaram 124 mulheres (Grupos Controle (GC) n = 33; 24,5 ± 2,9 anos e de Estudo (GE) n = 91; 61,9 ± 8,7 anos). Analisaram-se medidas antropométricas, parâmetros sanguíneos, composição corporal (DEXA), índices antropométricos e respostas de questionários. Considerou-se sarcopenia um desvio-padrão abaixo da média para a população jovem, correspondendo a 7,3 kg/m², classificando 34,1% do GE como sarcopênico. Prevalência do risco para DCV considerando baixo, moderado e alto foi, respectivamente, 21%, 60% e 19%. A regressão logística não mostrou relação entre sarcopenia e fatores de risco para DCV, exceto para o índice de massa corporal como fator de proteção. Observouse tendência da sarcopenia assumir associações como fator de risco nas variáveis tabagismo, triglicerídeos, obesidade, gordura abdominal e Escore de Risco de Framingham e como fator de proteção na variável nível de atividade física. Palavras-chave: sarcopenia, fatores de risco cardiovascular, mulheresResumen-"Sarcopenia y riesgo cardiovascular en mujeres adultas y mayores fisicamente activas." El objetivo fue comprobar la prevalencia de sarcopenia y su relación con factores de riesgo para el desarrollo de enfermedades cardiovasculares (ECV) en mujeres activas. Participaron 124 mujeres (Grupo Control (GC) n = 33; 24,5 ± 2,9 años y de Estudio (GE) n = 91; 61,9 ± 8,7 años), a las cuales se le realizó: cuestionario, antropometría, análisis bioquímico y densitometría ósea (DEXA). La sarcopenia fue considerada una desviación estándar por debajo de la media para la población joven, lo que corresponde a 7,3 kg/m², clasificando 34,1% el GE como sarcopénico. La prevalencia del riesgo para ECV considerando bajo, moderado y alt...

show abstract

Section: Discussioncontrasting

confidence: 49%

Section: Discussionmentioning

confidence: 99%

Sarcopenia and cardiovascular risk in physically active adult and elderly women

Castro

Lima

Cerqueira³

et al. 2014

Motriz: rev. educ. fis.

View full text Add to dashboard Cite

show abstract

“…11 In addition, Bogaerts et al 41 showed improvements in muscle strength and oxygen consumption after WBV training that included static and dynamic exercises that were comparable to a fitness group that combined RET and aerobic training, suggesting that WBV training is an efficient alternative for overall training effects. Because young obese individuals may develop high SBP, metabolic syndrome and sarcopenic obesity, which are associated with increased baPWV, 9,42 WBV training may be a beneficial exercise modality for the prevention of these comorbidities through improvements in arterial function and muscle strength.…”

Section: Discussionmentioning

confidence: 99%

“…8 The baPWV has been inversely associated with muscle mass in adults with metabolic syndrome. 9 Moreover, muscle strength has been inversely associated with aortic PWV 10 and the prevalence of obesity. 11 This evidence suggests that improvement of muscle function can occur concurrently with improved endothelial function in obese women.…”

Section: Introductionmentioning

confidence: 99%

Whole-body vibration training reduces arterial stiffness, blood pressure and sympathovagal balance in young overweight/obese women

et al. 2012

View full text Add to dashboard Cite

Obesity is associated with early cardiovascular dysfunction and reduced muscle strength. Whole-body vibration (WBV) training may improve arterial function and muscle strength. The effects of WBV training on arterial stiffness (brachial-ankle pulse wave velocity, baPWV), wave reflection (augmentation index, AIx), brachial systolic blood pressure (bSBP), aortic systolic blood pressure (aSBP), heart rate variability, and muscle strength (one-repetition maximum, 1RM) were examined in 10 young (21 ± 2 year) overweight/obese women (body mass index, BMI¼29.9 ± 0.8 kg m -2 ). Participants were randomized to a 6-week WBV training or non-exercising control (CON) period in a crossover design. WBV training (3 daysÂweek) consisted of static and dynamic squats and calf raises with vibration intensity at 25-30 Hz and 1-2 mm amplitude (2.83-4.86 G). There were significant (Po0.05) decreases in baPWV (À0.9±0.3 m s -1 ), AIx (À8.0±2.2 %), bSBP (À5.3±1.5 mm Hg), aSBP (À5.2 ± 2.1 mm Hg), low-frequency power (À0.13 ± 0.05 nu) and sympathovagal balance (LF/HF, À0.42 ± 0.16) after WBV training compared with CON. Significant (Po0.05) increases in high-frequency power (HF, 0.19 ± 0.04 nu) and leg extension 1RM (8.2±2.3 kg) occurred after WBV training compared with CON. Six weeks of WBV training decreased systemic arterial stiffness and aSBP via improvements in wave reflection and sympathovagal balance in young overweight/obese normotensive women. WBV training may benefit arterial function and muscle strength in deconditioned individuals who cannot perform conventional exercise.

show abstract

“…The prevalence of SO has increased in industrialized countries due to the high number of cases of obesity and sarcopenia in obese people, ranging from 4.4% to 42.9%, depending on the diagnostic methods and on the studied population (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21). There is not a consensus between the definition and classification of SO, and this gap contributes to the inconsistent findings in its association with clinical outcomes (22)(23)(24). Knowledge about the consequences of the SO to health were initially limited to functional outcomes.…”

Section: Introductionmentioning

confidence: 99%

Association between sarcopenic obesity and cardiovascular risk: where are we?

Gusmão-Sena¹,

Curvello-Silva

Barreto-Medeiros

et al. 2016

Nutr Hosp

View full text Add to dashboard Cite

ResumenIntroducción: los principales cambios en la composición del cuerpo refi eren el incremento de tejido adiposo y/o la disminución de masa muscular, y estos cambios tienen efecto en varios resultados clínicos. La obesidad sarcopénica (OS) consiste en la presencia simultánea del exceso de tejido adiposo y el défi cit de masa muscular. Las personas con OS pueden tener un efecto sinérgico debido a la obesidad y la sarcopenia, lo que incrementa el riesgo de enfermedad cardiovascular, más que la obesidad en sí. Objetivo: describir los hallazgos en la literatura científi ca sobre la asociación de la SO y los factores de riesgo y/o ECM (enfermedad cardiometabólica) o enfermedad cardiovascular (ECV). Métodos: se realizó una búsqueda electrónica en las siguientes bases de datos: MEDLINE, Scopus, SciELO, LILACS y Web of Science, usando las expresiones coincidentes y los operadores booleanos: "obesidad sarcopénica" o " sarcopénica obesidad ", en los títulos de los estudios, y "enfermedad cardiometabólica" o "enfermedad cardiovascular" o "síndrome metabólico" o "resistencia a la insulina", en el abstract. Resultados: la mayoría de los estudios son de corte transversales y presentan diferentes criterios de diagnóstico para la OS. Fue posible verifi car la asociación de la OS y los factores de riesgo y/o ECM o ECV. Conclusión: la OS está asociada con los factores de riesgo y/o ECM o ECV. La falta de un consenso sobre esta defi nición pone en peligro la efectividad de la práctica clínica y la investigación sobre el tema. AbstractIntroduction: The main changes in the body composition refer to the increase of adipose tissue and/or the decrease of muscular mass, and these changes have effect in many clinical outcomes. Sarcopenic obesity (SO) consists of the presence of excessive adipose tissue and defi cit of muscular mass simultaneously. People with SO may have synergistic effect due to obesity and sarcopenia, with increases cardiovascular risk more than obesity itself. Objective: To describe the fi ndings in the literature about the association between SO and risk factors and/or cardiometabolic disease (CMD) or cardiovascular disease (CVD). Methods: An electronic search was done on the following databases: MEDLINE, Scopus, SciELO, LILACS and Web of Science, using the matching expressions and Boolean operators: "obesity sarcopenic" OR "sarcopenic obesity", in the titles of the studies, AND "cardiometabolic disease" OR "cardiovascular disease" OR "metabolic syndrome" OR "insulin resistance", in the abstract. Results: Most of studies are cross-sectional and present many different diagnosis criteria for SO. It was possible to verify the association of the SO and the risk factors and/or CMD or CVD. Conclusion: SO is associated with risk factors and/or CMD or CVD. The lack of a consensus about this defi nition jeopardizes the effective clinical practice and the research about the subject.

show abstract

Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS)

Cited by 133 publications

References 33 publications

Sarcopenia and cardiovascular risk in physically active adult and elderly women

Sarcopenia and cardiovascular risk in physically active adult and elderly women

Whole-body vibration training reduces arterial stiffness, blood pressure and sympathovagal balance in young overweight/obese women

Association between sarcopenic obesity and cardiovascular risk: where are we?

Contact Info

Product

Resources

About